5 years ago677 views
Over 85,000 people in the UK suffer from the degenerative condition multiple sclerosis. Two hundred people are diagnosed in the UK every week and there are more than 2.5m sufferers worldwide.
While there is no universal treatment for MS, known treatments carry side effects such as depression and flu–like symptoms. Aimspro, developed by Daval International, has been trialed in the UK since 2003.
In this video, Patients who have been part of these trials explain how Aimspro helped reverse their symptoms with no apparent side effects. Later trials were also carried out on cancer patients giving them a new sense of hope for the future.
For more information visit: http://www.davalinternational.com/